MedTrace Logo

The Ward Study for SeptiCyte® Lab to Distinguish Between Infection-positive and Infection-negative SIRS

NCT02704871 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 66

Last updated 2018-03-01

No results posted yet for this study

Summary

A non-interventional, prospective observational study to assess the performance of SeptiCyte® Lab to diagnose patients identified as suspected of sepsis in general medical and surgical wards with infection-positive from infection-negative SIRS

Conditions

Interventions

OTHER

SeptiCyte Lab molecular diagnostic test (non-interventional)

This is not an interventional study. Rather it involves evaluation of a molecular diagnostic test to distinguish between sepsis and infection-negative SIRS based on host response.

Sponsors & Collaborators

  • Rhode Island Hospital

    collaborator OTHER

  • Immunexpress

    lead INDUSTRY

Principal Investigators

  • Mitchell Levy, MD · Rhode Island Hospital

  • Steven Opal, MD · Memorial Hospital of Rhode Island

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2016-04-30
Completion
2018-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02704871 on ClinicalTrials.gov